Laser-Assisted Gingival Depigmentation

Gingival Depigmentation With Er,Cr:YSGG and Diode Laser: Randomized Clinical Trial to Evaluate the Repigmentation and Patient Perceptions

This randomized clinical trial evaluated the recurrence rates of physiological gingival pigments during 24 months follow-up and the patient perceptions after the ablative depigmentation using two laser wavelengths; Diode 940 nm and Er,Cr:YSGG 2780 nm.

Study Overview

Detailed Description

This study aim to compare the clinical outcomes, the rate of repigmentation, and the patient perceptions after laser-assisted gingival depigmentation with diode 940 nm and Erbium, chromium-doped yttrium, scandium, gallium and garnet (Er,Cr:YSGG) 2780 nm. Two pigmentation index were used to compare between the treatment outcomes of using Diode laser or Er,Cr:YSGG.

The depigmentation procedure essentially involves ablation of epithelial layer of buccal gingiva containing melanin pigmentation.

Sixty healthy patients (22 males and 38 females, aged 21 to 43 years) who presented with a chief complaint of having dark-brown to black gingival hyperpigmentation between April 2015 and September 2018. Participants were randomly divided into 2 groups (30 patients each). Randomization was carried out using randomization table; by a computer-generated randomization list (SPSS v23.0) with allocation ratio 1:1.

All of the patients were selected according to the study inclusion and exclusion criteria.

Data collection was done by a dental specialist who was blinded about the provided treatment. Data collections included the clinical examination at baseline and follow up appointments. To achieve blinding, three calibrated external experts, blinded to the provided treatment classified the degree of gingival pigments and gingival topography according oral pigmentation index (DOPI) and melanin pigmentation index.

The periodontal surgery was performed by a periodontist specialised in laser dentistry. The periodontist did not interfere with the treatment option.

Descriptive statistics and statistical analysis was done by an external expert using SPSS Statistics software(SPSS v23.0) . Nonparametric tests, Kruskal-Wallis test was used to compare between the two groups according the time intervals.

The patients who did not show in all the study follow up's appointments were dropped from the data analysis.

Patients were asked to evaluate the procedure by using a self-administered questionnaire. The patients were recalled after 1 week, 1 month, 12 months and 24 months.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Doha, Qatar, 13876
        • Dr. Tamim Dental Polyclinic

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

• All patient exhibiting physiologic pigmentation of score2 or more according to Oral pigmentation index (DOPI)

Exclusion Criteria:

  • Pathologic hyperpigmentation
  • Participants with a systemic condition that could affect tissue healing (e. g., autoimmune diseases)
  • Pregnancy and lactation
  • History of smoking
  • Previous mucogingival surgery at the region to be treated
  • No contraindication for the laser treatment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Er,Cr:YSGG laser 2780 nm
Group A was treated by an Er,Cr:YSGG laser 2780 nm cylindrical tip (tip 600 μm, 45 millijoule /pulse, average power 2.25 W, frequency 50 Hz, pulse duration 60 µs, energy density 43 J/cm2, water 50%, and air 40%). The procedure was performed completely without anesthesia with the laser tip at angulation ~30° and distance of ~1 mm from the gingival tissue. The laser tip was advancing in scanning movement from in the cervical-apical direction in all pigmented areas. The following settings was used to achieve hemostasis in case of the bleeding was present (tip 600 μm, 30 millijoule /pulse, average power 1.5 W, frequency 50 Hz, pulse duration 700 µs, energy density 28.7 J/cm2, water 10%, and air 20%).
The depigmentation procedure essentially involves laser ablation of epithelial layer of buccal gingiva containing melanin pigmentation.
Experimental: Diode laser 940 nm
Group B was treated with diode 940 nm Laser. The procedure was performed with a pencil-sized handpiece containing a 400 µm lasing fiber (400 μm initiated tip, average power 0.8 watts, Pulsed mode, Duty cycle 20%, Pulse duration 10 μs, energy density 636.9 J/cm2 per second, no water or air). Infiltration anesthesia was injected for B group . The laser tip was placed in angle ~30° with the gingival surface. Short light paint brush strokes were used in the cervical-apical direction in all pigmented areas.
The depigmentation procedure essentially involves laser ablation of epithelial layer of buccal gingiva containing melanin pigmentation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oral pigmentation index (DOPI)
Time Frame: Baseline
  • Score 1: No clinical pigmentation (pink-colored gingiva)
  • Score 2: Mild clinical pigmentation (mild light brown color)
  • Score 3: Moderate clinical pigmentation (medium brown or mixed pink and brown color)
  • Score 4: Heavy clinical pigmentation (deep brown or bluish black color)
Baseline
Oral pigmentation index (DOPI)
Time Frame: 1 month post-operative
  • Score 1: No clinical pigmentation (pink-colored gingiva)
  • Score 2: Mild clinical pigmentation (mild light brown color)
  • Score 3: Moderate clinical pigmentation (medium brown or mixed pink and brown color)
  • Score 4: Heavy clinical pigmentation (deep brown or bluish black color)
1 month post-operative
Oral pigmentation index (DOPI)
Time Frame: 1 year follow-up
  • Score 1: No clinical pigmentation (pink-colored gingiva)
  • Score 2: Mild clinical pigmentation (mild light brown color)
  • Score 3: Moderate clinical pigmentation (medium brown or mixed pink and brown color)
  • Score 4: Heavy clinical pigmentation (deep brown or bluish black color)
1 year follow-up
Oral pigmentation index (DOPI)
Time Frame: 2 years follow-up
  • Score 1: No clinical pigmentation (pink-colored gingiva)
  • Score 2: Mild clinical pigmentation (mild light brown color)
  • Score 3: Moderate clinical pigmentation (medium brown or mixed pink and brown color)
  • Score 4: Heavy clinical pigmentation (deep brown or bluish black color)
2 years follow-up
Melanin pigmentation index:
Time Frame: Baseline
  • Score 0: No pigmentation
  • Score 1: Solitary unit(s) of pigmentation in papillary gingiva without extension between neighboring solitary units
  • Score 2: Formation of continuous ribbon extending from neighboring solitary units
Baseline
Melanin pigmentation index:
Time Frame: 1 month post-operative
  • Score 0: No pigmentation
  • Score 1: Solitary unit(s) of pigmentation in papillary gingiva without extension between neighboring solitary units
  • Score 2: Formation of continuous ribbon extending from neighboring solitary units
1 month post-operative
Melanin pigmentation index:
Time Frame: 1 year follow-up
  • Score 0: No pigmentation
  • Score 1: Solitary unit(s) of pigmentation in papillary gingiva without extension between neighboring solitary units
  • Score 2: Formation of continuous ribbon extending from neighboring solitary units
1 year follow-up
Melanin pigmentation index:
Time Frame: 2 years follow-up
  • Score 0: No pigmentation
  • Score 1: Solitary unit(s) of pigmentation in papillary gingiva without extension between neighboring solitary units
  • Score 2: Formation of continuous ribbon extending from neighboring solitary units
2 years follow-up
Gingival Appearance
Time Frame: 1 month
  • Score 1:Pink vital appearance for the gingiva
  • Score 2: Pale Non-vital appearance for gingiva
1 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oral Hygiene Index
Time Frame: Baseline

The Oral Hygiene Index is composed of the combined Debris Index and Calculus index, each of these index is in turn based on 12 numerical determinations representing the amount of debris or calculus found on the buccal and lingual surfaces of each of three segments of each dental arch.

Criteria for classifying debris 0 No debris or stain present

  1. Soft debris covering not more than one third of the tooth surface, or presence of extrinsic stains without other debris regardless of surface area covered
  2. Soft debris covering more than one third, but not more than two thirds, of the exposed tooth surface.
  3. Soft debris covering more than two thirds of the exposed tooth surface.
Baseline
Oral Hygiene Index
Time Frame: 1 month post-operative

The Oral Hygiene Index is composed of the combined Debris Index and Calculus index, each of these index is in turn based on 12 numerical determinations representing the amount of debris or calculus found on the buccal and lingual surfaces of each of three segments of each dental arch.

Criteria for classifying debris 0 No debris or stain present

  1. Soft debris covering not more than one third of the tooth surface, or presence of extrinsic stains without other debris regardless of surface area covered
  2. Soft debris covering more than one third, but not more than two thirds, of the exposed tooth surface.
  3. Soft debris covering more than two thirds of the exposed tooth surface.
1 month post-operative
Gingival Index
Time Frame: Baseline

The Gingival Index (Löe and Silness, 1963) was created for the assessment of the gingival condition and records qualitative changes in the gingiva. It scores the marginal and interproximal tissues separately on the basis of 0 to 3. The criteria are:

0= Normal gingiva;

1= Mild inflammation - slight change in color and slight edema but no bleeding on probing; 2= Moderate inflammation - redness, edema and glazing, bleeding on probing; 3= Severe inflammation - marked redness and edema, ulceration with tendency to spontaneous bleeding.

Baseline
Gingival Index
Time Frame: 1 month post-operative

The Gingival Index (Löe and Silness, 1963) was created for the assessment of the gingival condition and records qualitative changes in the gingiva. It scores the marginal and interproximal tissues separately on the basis of 0 to 3. The criteria are:

0= Normal gingiva;

1= Mild inflammation - slight change in color and slight edema but no bleeding on probing; 2= Moderate inflammation - redness, edema and glazing, bleeding on probing; 3= Severe inflammation - marked redness and edema, ulceration with tendency to spontaneous bleeding.

1 month post-operative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Director: Omar Hamadah, PhD, Damascus University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 5, 2015

Primary Completion (Actual)

September 30, 2018

Study Completion (Actual)

October 20, 2019

Study Registration Dates

First Submitted

December 15, 2020

First Submitted That Met QC Criteria

December 18, 2020

First Posted (Actual)

December 23, 2020

Study Record Updates

Last Update Posted (Actual)

December 23, 2020

Last Update Submitted That Met QC Criteria

December 18, 2020

Last Verified

December 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

there is no plan to make individual participant data (IPD) available

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hyperpigmentation; Melanin

Clinical Trials on Er,Cr:YSGG laser 2780 nm

3
Subscribe